Literature DB >> 1255327

A study of factors that influence the severity of neonatal narcotic withdrawal.

E M Ostrea, C J Chavez, M E Strauss.   

Abstract

A prospective study of 196 drug-addicted mothers and their infants was conducted to determine the maternal, fetal, or environmental factors that may affect the severity of narcotic withdrawal in the infants. The severity of neonatal withdrawal did not correlate with the infant's gestational age, sex, race, or Apgar score, not to maternal age, parity, duration of heroin intake, or the level of morphine measured in the infant's urine or blood. Reduction in the amount of illumination and noise in a study nursery also did not lower the incidence of severe withdrawal in the infants. There was, however, significant correlation between the severity of withdrawal in the infant and the maternal methadone dose (p less than 0.025). It is therefore recommended that mothers on methadone treatment be put on a low dose of the drug (less than 20 mg/day) as soon as is safely possible to prevent serious withdrawal in her infant.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255327     DOI: 10.1016/s0022-3476(76)80027-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

Review 1.  Detoxification considerations in the medical management of substance abuse in pregnancy.

Authors:  M H Allen
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun

Review 2.  Drug addiction and pregnancy: policy crossroads.

Authors:  W Chavkin
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

3.  Statement on drug use in pregnancy: an urgent problem for New York City. Committee on Public Health. The New York Academy of Medicine.

Authors: 
Journal:  Bull N Y Acad Med       Date:  1990 Mar-Apr

4.  Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.

Authors:  Annemarie Unger; Erika Jung; Bernadette Winklbaur; Gabriele Fischer
Journal:  J Addict Dis       Date:  2010-04

Review 5.  Impact of maternal substance use during pregnancy on childhood outcome.

Authors:  Seetha Shankaran; Barry M Lester; Abhik Das; Charles R Bauer; Henrietta S Bada; Linda Lagasse; Rosemary Higgins
Journal:  Semin Fetal Neonatal Med       Date:  2007-02-20       Impact factor: 3.926

6.  Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.

Authors:  Alexander G Agthe; George R Kim; Kay B Mathias; Craig W Hendrix; Raul Chavez-Valdez; Lauren Jansson; Tamorah R Lewis; Myron Yaster; Estelle B Gauda
Journal:  Pediatrics       Date:  2009-04-27       Impact factor: 7.124

7.  Central and autonomic system signs with in utero drug exposure.

Authors:  H S Bada; C R Bauer; S Shankaran; B Lester; L L Wright; A Das; K Poole; V L Smeriglio; L P Finnegan; P L Maza
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

8.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

9.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

10.  Opioid treatment for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.